He designs and implements solutions to make HIV pre and post-exposure prophylaxis (PrEP and PEP) more accessible to gay, bisexual and other men who have sex with men, as well as other key populations in Canada.
Dr. Tan is the director of the University of Toronto Clinical Research Unit on HIV Prevention and co-leader of the CIHR Canadian HIV Trials Network Biomedical Prevention Working Group.
Dr. Tan is a scientist with MAP Centre for Urban Health Solutions in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. He is also a clinician-scientist in the St. Michael’s Hospital Department of Medicine, and an affiliate scientist with the Toronto General Research Institute. He is an assistant professor in the University of Toronto’s Department of Medicine as well as the Institute of Health Policy, Management & Evaluation.
Learn more about Dr. Tan’s work via the links below, and at optionslab.ca.